Groupe la Francaise Takes $3.49 Million Position in Surgery Partners, Inc. $SGRY

Key Points

• Groupe la Francaise acquired 146,999 shares of Surgery Partners, Inc., valued at approximately $3.49 million, representing about 0.11% of the company.
• Surgery Partners reported a quarterly profit of $0.17 EPS, surpassing analysts' expectations, and recorded a revenue of $826.20 million, a growth of 8.4% compared to the previous year.
• Several institutional investors, including AlphaQuest LLC and PNC Financial Services Group, have increased their stakes in Surgery Partners, indicating growing interest in the company's stock.

Groupe la Francaise purchased a new stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The firm purchased 146,999 shares of the company's stock, valued at approximately $3,491,000. Groupe la Francaise owned approximately 0.11% of Surgery Partners as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in SGRY. LPL Financial LLC increased its holdings in Surgery Partners by 22.4% during the 4th quarter. LPL Financial LLC now owns 16,749 shares of the company's stock valued at $355,000 after acquiring an additional 3,062 shares in the last quarter. Wells Fargo & Company MN boosted its stake in shares of Surgery Partners by 1.4% during the 4th quarter. Wells Fargo & Company MN now owns 56,931 shares of the company's stock worth $1,205,000 after purchasing an additional 783 shares during the last quarter. Envestnet Asset Management Inc. boosted its stake in shares of Surgery Partners by 17.9% during the 4th quarter. Envestnet Asset Management Inc. now owns 32,707 shares of the company's stock worth $692,000 after purchasing an additional 4,954 shares during the last quarter. Barclays PLC boosted its stake in shares of Surgery Partners by 9.3% during the 4th quarter. Barclays PLC now owns 141,094 shares of the company's stock worth $2,987,000 after purchasing an additional 11,961 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Surgery Partners by 18.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,577,861 shares of the company's stock worth $75,739,000 after purchasing an additional 563,812 shares during the last quarter.

Surgery Partners Trading Down 0.2%

SGRY stock traded down $0.04 during midday trading on Friday, reaching $22.68. 464,023 shares of the company's stock traded hands, compared to its average volume of 1,399,516. The company has a market capitalization of $2.91 billion, a P/E ratio of -15.86 and a beta of 1.82. The business has a 50-day moving average price of $22.29 and a two-hundred day moving average price of $22.83. Surgery Partners, Inc. has a fifty-two week low of $18.87 and a fifty-two week high of $33.90. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.93 and a quick ratio of 1.78.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.01. The company had revenue of $826.20 million for the quarter, compared to analyst estimates of $816.96 million. Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The business's quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.21 earnings per share. Equities research analysts forecast that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have issued reports on SGRY. Barclays decreased their price target on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 27th. Bank of America began coverage on shares of Surgery Partners in a research note on Monday, July 28th. They set a "buy" rating and a $28.00 price target on the stock. Six research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $33.00.

Insider Activity

In related news, Director Teresa Deluca sold 20,018 shares of Surgery Partners stock in a transaction on Monday, August 11th. The shares were sold at an average price of $22.74, for a total value of $455,209.32. Following the completion of the sale, the director owned 45,173 shares in the company, valued at approximately $1,027,234.02. The trade was a 30.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.70% of the company's stock.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.